HomeSHRX • CVE
add
Sharp Therapeutics Corp
Previous close
$0.75
Day range
$0.50 - $0.50
Year range
$0.50 - $2.28
Market cap
14.99M CAD
Avg Volume
147.00
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.43M | 24.75% |
Net income | 559.10K | 130.97% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.43M | -25.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.15M | 1,246.61% |
Total assets | 4.22M | 203.94% |
Total liabilities | 1.76M | -88.91% |
Total equity | 2.46M | — |
Shares outstanding | 29.97M | — |
Price to book | 9.38 | — |
Return on assets | -97.21% | — |
Return on capital | -162.93% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 559.10K | 130.97% |
Cash from operations | -1.35M | -98.26% |
Cash from investing | — | — |
Cash from financing | 2.43M | 102.67% |
Net change in cash | 1.13M | 2,871.14% |
Free cash flow | -2.87M | — |
About
Founded
2021
Headquarters
Website
